Company · CIK 0001145460 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances
ALERE INC. · ALR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2017 DForm 4 → | Oct 3, 5:42 pm EDT | Jonathan WygantVP, Controller, CAO | 1,909 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:41 pm EDT | Renuka UppaluriSenior VP, Global R&D | 13,267 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:40 pm EDT | James Roosevelt Jr.Director | 9,974 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:40 pm EDT | John QuelchDirector | 26,651 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:39 pm EDT | Gregg J PowersDirector | 51,530 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:39 pm EDT | Avi PelossofGlobalPres, Infectious Disease | 26,005 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:38 pm EDT | Namal NawanaChief Executive Officer, Director | 174,129 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:38 pm EDT | Thomas McKillopDirector | 5,530 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:37 pm EDT | Brian A MarkisonDirector | 5,530 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:36 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 29,322 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:36 pm EDT | John F LevyDirector | 172,223 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:35 pm EDT | James F. HinrichsExecutive VP, CFO | 72,230 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:34 pm EDT | Robert Bernard HargadonSVP, Global Human Resources | 26,190 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:34 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 16,385 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:33 pm EDT | Carol R GoldbergDirector | 85,211 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:33 pm EDT | Mark GladwellSenior VP, Global Operations | 9,791 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:32 pm EDT | Geoffrey S GinsburgDirector | 5,530 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:32 pm EDT | Daniella CrampGlobal Pres., Cardiometabolic | 28,573 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:31 pm EDT | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 32,764 | — | — | 0 | — | plan? |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:30 pm EDT | John BridgenSr VP, Business Development | 20,646 | — | — | 0 | — | plan? |
| Aug 31, 2017 FMForm 4 → | Sep 5, 7:51 pm EDT | Daniella CrampGlobal Pres., Cardiometabolic | 28,921 | $48.87 | $1,087,483 | 28,298 | — | plan? |
| Aug 31, 2017 FMForm 4 → | Sep 5, 7:43 pm EDT | John BridgenSr VP, Business Develop | 6,879 | $49.46 | $92,935 | 20,646 | — | plan? |
| Aug 31, 2017 FMForm 4 → | Sep 5, 7:43 pm EDT | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 8,830 | $49.46 | $106,982 | 32,764 | — | plan? |
| Aug 31, 2017 FMForm 4 → | Sep 5, 7:42 pm EDT | Mark GladwellSenior VP, Global Operations | 7,350 | $49.46 | $116,231 | 9,791 | — | plan? |
| Aug 31, 2017 FMForm 4 → | Sep 5, 7:41 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 11,465 | $49.46 | $154,859 | 16,385 | — | plan? |
| Aug 31, 2017 FMForm 4 → | Sep 5, 7:40 pm EDT | Robert Bernard HargadonSVP, Global Human Resources | 8,490 | $49.46 | $90,166 | 26,190 | — | plan? |
| Aug 31, 2017 FMForm 4 → | Sep 5, 7:32 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 8,705 | $49.46 | $100,799 | 28,757 | — | plan? |
| Aug 31, 2017 FMForm 4 → | Sep 5, 7:31 pm EDT | Avi PelossofGlobalPres, Infectious Disease | 9,131 | $49.46 | $121,869 | 26,005 | — | plan? |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:15 pm EDT | Carol R GoldbergDirector | 5,530 | — | — | 40,614 | — | plan? |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:14 pm EDT | John F LevyDirector | 5,530 | — | — | 163,655 | — | plan? |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:13 pm EDT | Brian A MarkisonDirector | 5,530 | — | — | 5,530 | — | plan? |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:11 pm EDT | Thomas McKillopDirector | 5,530 | — | — | 5,530 | — | plan? |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:11 pm EDT | Gregg J PowersDirector | 5,530 | — | — | 5,530 | — | plan? |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:09 pm EDT | Geoffrey S GinsburgDirector | 5,530 | — | — | 5,530 | — | plan? |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:07 pm EDT | John QuelchDirector | 5,530 | — | — | 26,651 | — | plan? |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:06 pm EDT | James Roosevelt Jr.Director | 5,530 | — | — | 9,974 | — | plan? |
| Apr 6, 2017 MForm 4 → | Apr 10, 6:18 pm EDT | James F. HinrichsExecutive VP, CFO | 16,667 | — | — | 72,230 | — | plan? |
| Feb 28, 2017 FMForm 4 → | Mar 2, 6:08 pm EST | Renuka UppaluriSenior VP, Global R&D | 9,172 | $38.30 | $95,942 | 13,267 | — | plan? |
| Feb 16, 2017 FMForm 4 → | Feb 21, 6:25 pm EST | Renuka UppaluriSenior VP, Global R&D | 11,332 | $40.40 | $128,028 | 9,105 | — | plan? |
| Feb 16, 2017 FMForm 4 → | Feb 21, 6:22 pm EST | Avi PelossofGlobalPres, Infectious Disease | 13,401 | $40.40 | $148,066 | 21,802 | — | plan? |
| Feb 16, 2017 FMForm 4 → | Feb 21, 6:21 pm EST | Namal NawanaChief Executive Officer, Director | 65,764 | $40.40 | $750,470 | 147,654 | — | plan? |
| Feb 16, 2017 FMForm 4 → | Feb 21, 6:19 pm EST | Sanjay MalkaniGlobal Pres., Toxicology | 12,763 | $40.40 | $122,291 | 24,128 | — | plan? |
| Feb 16, 2017 FMForm 4 → | Feb 21, 6:18 pm EST | James F. HinrichsExecutive VP, CFO | 19,102 | $40.40 | $212,504 | 55,563 | — | plan? |
| Feb 16, 2017 FMForm 4 → | Feb 21, 6:16 pm EST | Robert Bernard HargadonSVP, Global Human Resources | 10,490 | $40.40 | $94,011 | 21,346 | — | plan? |
| Feb 16, 2017 FMForm 4 → | Feb 21, 6:15 pm EST | Melissa GuerdanSVP, Global Quality & Reg. | 13,492 | $40.40 | $151,742 | 11,182 | — | plan? |
| Feb 16, 2017 FMForm 4 → | Feb 21, 6:13 pm EST | Mark GladwellSenior VP, Global Operations | 11,998 | $40.40 | $154,934 | 7,141 | — | plan? |
| Feb 16, 2017 FMForm 4 → | Feb 21, 6:09 pm EST | Daniella CrampGlobal Pres., Cardiometabolic | 13,470 | $40.40 | $150,854 | 23,885 | — | plan? |
| Feb 16, 2017 FMForm 4 → | Feb 21, 6:08 pm EST | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 12,979 | $40.40 | $131,017 | 28,260 | — | plan? |
| Feb 16, 2017 FMForm 4 → | Feb 21, 6:05 pm EST | John BridgenSr VP, Business Develop | 11,308 | $40.40 | $127,058 | 17,525 | — | plan? |
| Jan 15, 2017 FMForm 4 → | Jun 16, 6:50 pm EDT | Namal NawanaChief Executive Officer, Director | 73,525 | $39.89 | $938,412 | 145,517 | — | plan? late |
| Jan 15, 2017 FMForm 4 → | Jan 17, 5:51 pm EST | Jonathan WygantVP, Controller, CAO | 4,759 | $39.89 | $56,843 | 1,909 | — | plan? |
| Dec 30, 2016 FMForm 4 → | Jan 4, 2017, 7:16 pm EST | Avi PelossofGlobalPres, Infectious Disease | 79,793 | $38.84 | $3,099,131 | 15,731 | — | plan? |
| Nov 30, 2016 JForm 5 → | Feb 15, 2017, 6:09 pm EST | Sanjay MalkaniGlobal Pres., Toxicology | 315 | $33.73 | $10,624 | 17,419 | — | plan? |
| Nov 30, 2016 JForm 5 → | Feb 15, 2017, 6:01 pm EST | James F. HinrichsExecutive VP, CFO | 315 | $33.73 | $10,624 | 46,981 | — | plan? |
| Nov 30, 2016 JForm 5 → | Feb 15, 2017, 6:00 pm EST | Daniella CrampGlobal Pres., Cardiometabolic | 315 | $33.73 | $10,624 | 17,883 | — | plan? |
| Nov 30, 2016 JForm 5 → | Feb 15, 2017, 5:58 pm EST | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 238 | $33.73 | $8,027 | 21,767 | — | plan? |
| Oct 31, 2016 FMForm 4 → | Nov 2, 7:17 pm EDT | Namal NawanaChief Executive Officer, Director | 24,517 | $44.68 | $350,738 | 119,042 | — | plan? |
| Oct 14, 2016 FMForm 4 → | Oct 18, 5:40 pm EDT | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 43,891 | $39.98 | $1,754,868 | 21,529 | — | plan? |
| Oct 3, 2016 FMForm 4 → | Oct 5, 5:26 pm EDT | Mark GladwellSenior VP, Global Operations | 2,837 | $38.57 | $109,412 | 2,813 | — | plan? |
| Sep 9, 2016 MForm 4 → | Sep 13, 6:07 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 6,667 | — | — | 17,104 | — | plan? |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:31 pm EDT | Daniella CrampGlobal Pres., Cardiometabolic | 6,667 | — | — | 17,568 | — | plan? |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:26 pm EDT | Avi PelossofGlobalPres, Infectious Disease | 6,667 | — | — | 15,524 | — | plan? |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:25 pm EDT | James F. HinrichsExecutive VP, CFO | 16,666 | — | — | 46,666 | — | plan? |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:25 pm EDT | Robert Bernard HargadonSVP, Global Human Resources | 6,667 | — | — | 15,510 | — | plan? |
| Sep 9, 2016 FMForm 4 → | Sep 13, 5:24 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 11,464 | $42.34 | $132,567 | 5,202 | — | plan? |
| Sep 9, 2016 FMForm 4 → | Sep 13, 5:24 pm EDT | Mark GladwellSenior VP, Global Operations | 7,350 | $42.34 | $99,499 | 2,650 | — | plan? |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:23 pm EDT | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 6,667 | — | — | 15,420 | — | plan? |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:22 pm EDT | John BridgenSr VP, Business Develop | 5,000 | — | — | 12,507 | — | plan? |
| Feb 28, 2016 FMForm 4 → | Mar 2, 5:24 pm EST | Renuka UppaluriSenior VP, Global R&D | 9,221 | — | — | 4,111 | — | plan? late |
| Feb 3, 2016 FMForm 4 → | Mar 2, 5:23 pm EST | Namal NawanaChief Executive Officer, Director | 70,824 | — | — | 110,225 | — | plan? late |
| Feb 1, 2016 SForm 4 → | Feb 3, 5:24 pm EST | Melissa GuerdanSVP, Global Quality & Reg. | 2,500 | $54.00 | $135,000 | 0 | −100% | plan? |
| Feb 1, 2016 MForm 4 → | Feb 3, 5:24 pm EST | Melissa GuerdanSVP, Global Quality & Reg. | 2,500 | $33.73 | $84,325 | 2,500 | — | plan? |
| Dec 31, 2015 JForm 4 → | Feb 18, 2016, 5:29 pm EST | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 232 | $33.23 | $7,709 | 8,753 | — | plan? late |
| Dec 31, 2015 JForm 4 → | Feb 18, 2016, 5:29 pm EST | Daniella CrampGlobal Pres., Cardiometabolic | 232 | $33.23 | $7,709 | 10,901 | — | plan? late |
| Dec 31, 2015 JForm 4 → | Feb 18, 2016, 5:29 pm EST | Carla FlakneVP, Chief Accounting Officer | 232 | $33.23 | $7,709 | 5,673 | — | plan? late |
| Dec 31, 2015 JForm 4 → | Feb 18, 2016, 5:29 pm EST | Sanjay MalkaniGlobal Pres., Toxicology | 232 | $33.23 | $7,709 | 10,437 | — | plan? late |
| Dec 30, 2015 FMForm 4 → | Jan 4, 2016, 5:10 pm EST | Namal NawanaChief Executive Officer, Director | 134,661 | — | — | 81,049 | — | plan? |
| Nov 13, 2015 PForm 4 → | Nov 16, 9:30 am EST | Robert Bernard HargadonSVP, Global Human Resources | 1,000 | $38.99 | $38,990 | 8,843 | +12.8% | plan? |
| Nov 12, 2015 PForm 4 → | Nov 12, 1:49 pm EST | James F. HinrichsExecutive VP, CFO | 10,000 | $39.97 | $399,700 | 30,000 | +50.0% | plan? |
| Oct 31, 2015 FMForm 4 → | Nov 3, 9:38 pm EST | Namal NawanaChief Executive Officer, Director | 23,525 | — | — | 15,710 | — | plan? |
| Sep 3, 2015 SForm 4 → | Sep 4, 4:01 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 5,135 | $52.00 | $267,020 | 0 | −100% | plan? |
| Sep 3, 2015 SForm 4 → | Sep 4, 4:01 pm EDT | Mark GladwellSenior VP, Global Operations | 2,651 | $52.27 | $138,555 | 0 | −100% | plan? |
| Sep 1, 2015 SForm 4 → | Sep 2, 4:51 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 5,000 | $50.48 | $252,413 | 5,135 | −49.3% | plan? |
| Aug 31, 2015 SForm 4 → | Sep 2, 4:52 pm EDT | Mark GladwellSenior VP, Global Operations | 27,513 | $52.23 | $1,437,059 | 2,651 | −91.2% | plan? |
| Aug 31, 2015 FMForm 4 → | Sep 2, 4:52 pm EDT | Mark GladwellSenior VP, Global Operations | 34,862 | $27.06 | $808,206 | 30,164 | — | plan? |
| Aug 31, 2015 FMForm 4 → | Sep 2, 4:52 pm EDT | Robert Bernard HargadonSVP, Global Human Resources | 8,489 | $51.97 | $94,741 | 7,843 | — | plan? |
| Aug 31, 2015 FMForm 4 → | Sep 2, 4:51 pm EDT | Avi PelossofGlobalPres, Infectious Disease | 9,130 | $51.97 | $128,054 | 8,857 | — | plan? |
| Aug 31, 2015 FMForm 4 → | Sep 2, 4:51 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 16,531 | $31.73 | $260,100 | 10,135 | — | plan? |
| Aug 31, 2015 FMForm 4 → | Sep 2, 4:50 pm EDT | John BridgenSr VP, Business Develop | 7,045 | $51.97 | $106,279 | 7,507 | — | plan? |
| Aug 14, 2015 SForm 4 → | Aug 18, 4:50 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 31,460 | $54.60 | $1,717,716 | 6,222 | −83.5% | plan? |
| Aug 14, 2015 MForm 4 → | Aug 18, 4:50 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 31,460 | $31.35 | $986,324 | 37,682 | — | plan? |
| Aug 7, 2015 PForm 4 → | Aug 10, 2:16 pm EDT | James F. HinrichsExecutive VP, CFO | 20,000 | $49.33 | $986,570 | 20,000 | — | plan? |
| Jun 30, 2015 FJMForm 4 → | Sep 2, 4:53 pm EDT | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 9,102 | $49.74 | $121,164 | 8,521 | — | plan? late |
| Jun 30, 2015 FJMForm 4 → | Sep 2, 4:51 pm EDT | Daniella CrampGlobal Pres., Cardiometabolic | 9,504 | $49.61 | $140,788 | 10,669 | — | plan? late |
| Jun 30, 2015 FJMForm 4 → | Sep 2, 4:50 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 10,015 | $49.97 | $167,345 | 10,205 | — | plan? late |
| Jun 9, 2015 FGJMForm 4 → | Sep 2, 4:52 pm EDT | Carla FlakneVP, Chief Accounting Officer | 4,963 | $48.28 | $64,021 | 5,441 | — | plan? late |
| Jun 8, 2015 SForm 4 → | Jun 10, 5:03 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 24,331 | $50.87 | $1,237,645 | 6,222 | −79.6% | plan? |
| Jun 8, 2015 MForm 4 → | Jun 10, 5:03 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 24,331 | $19.19 | $466,905 | 30,553 | — | plan? |
| Jun 4, 2015 SForm 4 → | Jun 8, 4:48 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 15,669 | $52.18 | $817,640 | 6,222 | −71.6% | plan? |
| Jun 4, 2015 MForm 4 → | Jun 8, 4:48 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 15,669 | $35.44 | $555,245 | 21,891 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2017 DForm 4 → | Oct 3, 5:42 pm EDT | Jonathan WygantVP, Controller, CAO | 6,666 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:41 pm EDT | Renuka UppaluriSenior VP, Global R&D | 97,991 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:40 pm EDT | James Roosevelt Jr.Director | 98,841 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:40 pm EDT | John QuelchDirector | 97,610 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:39 pm EDT | Gregg J PowersDirector | 39,820 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:39 pm EDT | Avi PelossofGlobalPres, Infectious Disease | 216,426 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:38 pm EDT | Namal NawanaChief Executive Officer, Director | 784,118 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:38 pm EDT | Thomas McKillopDirector | 53,756 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:37 pm EDT | Brian A MarkisonDirector | 53,756 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:36 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 193,918 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:36 pm EDT | John F LevyDirector | 105,430 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:35 pm EDT | James F. HinrichsExecutive VP, CFO | 402,468 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:34 pm EDT | Robert Bernard HargadonSVP, Global Human Resources | 87,974 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:34 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 71,931 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:33 pm EDT | Carol R GoldbergDirector | 75,200 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:33 pm EDT | Mark GladwellSenior VP, Global Operations | 73,102 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:32 pm EDT | Daniella CrampGlobal Pres., Cardiometabolic | 248,179 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:31 pm EDT | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 97,314 | — | — | 0 | — | |
| Oct 3, 2017 DForm 4 → | Oct 3, 5:30 pm EDT | John BridgenSr VP, Business Development | 66,362 | — | — | 0 | — | |
| Aug 31, 2017 MForm 4 → | Sep 5, 7:51 pm EDT | Daniella CrampGlobal Pres., Cardiometabolic | 16,667 | — | — | 0 | — | |
| Aug 31, 2017 MForm 4 → | Sep 5, 7:43 pm EDT | John BridgenSr VP, Business Develop | 5,000 | — | — | 0 | — | |
| Aug 31, 2017 MForm 4 → | Sep 5, 7:43 pm EDT | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 6,667 | — | — | 0 | — | |
| Aug 31, 2017 MForm 4 → | Sep 5, 7:42 pm EDT | Mark GladwellSenior VP, Global Operations | 5,000 | — | — | 0 | — | |
| Aug 31, 2017 MForm 4 → | Sep 5, 7:41 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 8,334 | — | — | 0 | — | |
| Aug 31, 2017 MForm 4 → | Sep 5, 7:40 pm EDT | Robert Bernard HargadonSVP, Global Human Resources | 6,667 | — | — | 0 | — | |
| Aug 31, 2017 MForm 4 → | Sep 5, 7:32 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 6,667 | — | — | 0 | — | |
| Aug 31, 2017 MForm 4 → | Sep 5, 7:31 pm EDT | Avi PelossofGlobalPres, Infectious Disease | 6,667 | — | — | 0 | — | |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:15 pm EDT | Carol R GoldbergDirector | 5,530 | — | — | 0 | — | |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:14 pm EDT | John F LevyDirector | 5,530 | — | — | 0 | — | |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:13 pm EDT | Brian A MarkisonDirector | 5,530 | — | — | 0 | — | |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:11 pm EDT | Thomas McKillopDirector | 5,530 | — | — | 0 | — | |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:11 pm EDT | Gregg J PowersDirector | 5,530 | — | — | 0 | — | |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:09 pm EDT | Geoffrey S GinsburgDirector | 5,530 | — | — | 0 | — | |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:07 pm EDT | John QuelchDirector | 5,530 | — | — | 0 | — | |
| Jun 30, 2017 MForm 4 → | Jul 5, 9:06 pm EDT | James Roosevelt Jr.Director | 5,530 | — | — | 0 | — | |
| Apr 6, 2017 MForm 4 → | Apr 10, 6:18 pm EDT | James F. HinrichsExecutive VP, CFO | 16,667 | — | — | 16,667 | — | |
| Feb 28, 2017 MForm 4 → | Mar 2, 6:08 pm EST | Renuka UppaluriSenior VP, Global R&D | 6,667 | — | — | 6,667 | — | |
| Feb 16, 2017 MForm 4 → | Feb 21, 6:25 pm EST | Renuka UppaluriSenior VP, Global R&D | 8,163 | — | — | 11,324 | — | |
| Feb 16, 2017 MForm 4 → | Feb 21, 6:22 pm EST | Avi PelossofGlobalPres, Infectious Disease | 9,736 | — | — | 14,470 | — | |
| Feb 16, 2017 MForm 4 → | Feb 21, 6:21 pm EST | Namal NawanaChief Executive Officer, Director | 47,188 | — | — | 94,374 | — | |
| Feb 16, 2017 MForm 4 → | Feb 21, 6:19 pm EST | Sanjay MalkaniGlobal Pres., Toxicology | 9,736 | — | — | 14,470 | — | |
| Feb 16, 2017 MForm 4 → | Feb 21, 6:18 pm EST | James F. HinrichsExecutive VP, CFO | 13,842 | — | — | 27,683 | — | |
| Feb 16, 2017 MForm 4 → | Feb 21, 6:16 pm EST | Robert Bernard HargadonSVP, Global Human Resources | 8,163 | — | — | 11,324 | — | |
| Feb 16, 2017 MForm 4 → | Feb 21, 6:15 pm EST | Melissa GuerdanSVP, Global Quality & Reg. | 9,736 | — | — | 14,470 | — | |
| Feb 16, 2017 MForm 4 → | Feb 21, 6:13 pm EST | Mark GladwellSenior VP, Global Operations | 8,163 | — | — | 11,324 | — | |
| Feb 16, 2017 MForm 4 → | Feb 21, 6:09 pm EST | Daniella CrampGlobal Pres., Cardiometabolic | 9,736 | — | — | 14,470 | — | |
| Feb 16, 2017 MForm 4 → | Feb 21, 6:08 pm EST | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 9,736 | — | — | 14,470 | — | |
| Feb 16, 2017 MForm 4 → | Feb 21, 6:05 pm EST | John BridgenSr VP, Business Develop | 8,163 | — | — | 11,324 | — | |
| Jan 15, 2017 MForm 4 → | Jun 16, 6:50 pm EDT | Namal NawanaChief Executive Officer, Director | 50,000 | — | — | 50,000 | — | late |
| Jan 15, 2017 MForm 4 → | Jan 17, 5:51 pm EST | Jonathan WygantVP, Controller, CAO | 3,334 | — | — | 6,666 | — | |
| Dec 30, 2016 MForm 4 → | Jan 4, 2017, 7:16 pm EST | Avi PelossofGlobalPres, Infectious Disease | 40,000 | — | — | 0 | — | |
| Nov 15, 2016 AForm 4 → | Nov 17, 5:59 pm EST | James Roosevelt Jr.Director | 5,530 | — | — | 5,530 | — | |
| Nov 15, 2016 AForm 4 → | Nov 17, 5:59 pm EST | John QuelchDirector | 5,530 | — | — | 5,530 | — | |
| Nov 15, 2016 AForm 4 → | Nov 17, 5:57 pm EST | Gregg J PowersDirector | 5,530 | — | — | 5,530 | — | |
| Nov 15, 2016 AForm 4 → | Nov 17, 5:56 pm EST | Thomas McKillopDirector | 5,530 | — | — | 5,530 | — | |
| Nov 15, 2016 AForm 4 → | Nov 17, 5:55 pm EST | Brian A MarkisonDirector | 5,530 | — | — | 5,530 | — | |
| Nov 15, 2016 AForm 4 → | Nov 17, 5:54 pm EST | John F LevyDirector | 5,530 | — | — | 5,530 | — | |
| Nov 15, 2016 AForm 4 → | Nov 17, 5:53 pm EST | Carol R GoldbergDirector | 5,530 | — | — | 5,530 | — | |
| Nov 15, 2016 AForm 4 → | Nov 17, 5:52 pm EST | Geoffrey S GinsburgDirector | 5,530 | — | — | 5,530 | — | |
| Nov 15, 2016 AForm 4 → | Nov 17, 5:51 pm EST | Hakan BjorklundDirector | 5,530 | — | — | 5,530 | — | |
| Oct 31, 2016 MForm 4 → | Nov 2, 7:17 pm EDT | Namal NawanaChief Executive Officer, Director | 16,667 | — | — | 16,667 | — | |
| Oct 14, 2016 MForm 4 → | Oct 18, 5:40 pm EDT | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 25,000 | — | — | 0 | — | |
| Oct 3, 2016 MForm 4 → | Oct 5, 5:26 pm EDT | Mark GladwellSenior VP, Global Operations | 1,500 | — | — | 0 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 6:07 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 6,667 | — | — | 6,667 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:31 pm EDT | Daniella CrampGlobal Pres., Cardiometabolic | 6,667 | — | — | 6,667 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:26 pm EDT | Avi PelossofGlobalPres, Infectious Disease | 6,667 | — | — | 6,667 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:25 pm EDT | James F. HinrichsExecutive VP, CFO | 16,666 | — | — | 33,334 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:25 pm EDT | Robert Bernard HargadonSVP, Global Human Resources | 6,667 | — | — | 6,667 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:24 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 8,333 | — | — | 8,334 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:24 pm EDT | Mark GladwellSenior VP, Global Operations | 5,000 | — | — | 5,000 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:23 pm EDT | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 6,667 | — | — | 6,667 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 5:22 pm EDT | John BridgenSr VP, Business Develop | 5,000 | — | — | 5,000 | — | |
| Feb 28, 2016 MForm 4 → | Mar 2, 5:24 pm EST | Renuka UppaluriSenior VP, Global R&D | 6,666 | — | — | 13,332 | — | late |
| Feb 16, 2016 AForm 4 → | Feb 18, 5:29 pm EST | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 29,206 | — | — | 7,500 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 5:29 pm EST | Daniella CrampGlobal Pres., Cardiometabolic | 29,206 | — | — | 7,500 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 5:29 pm EST | Carla FlakneVP, Chief Accounting Officer | 4,246 | — | — | 4,246 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 5:29 pm EST | Sanjay MalkaniGlobal Pres., Toxicology | 29,206 | — | — | 7,500 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 5:28 pm EST | John BridgenSr VP, Business Develop | 24,487 | — | — | 7,500 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 5:28 pm EST | Avi PelossofGlobalPres, Infectious Disease | 29,206 | — | — | 7,500 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 5:27 pm EST | Melissa GuerdanSVP, Global Quality & Reg. | 29,206 | — | — | 7,500 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 5:27 pm EST | Renuka UppaluriSenior VP, Global R&D | 24,487 | — | — | 7,500 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 5:27 pm EST | Mark GladwellSenior VP, Global Operations | 24,487 | — | — | 7,500 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 5:26 pm EST | Robert Bernard HargadonSVP, Global Human Resources | 24,487 | — | — | 7,500 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 5:26 pm EST | James F. HinrichsExecutive VP, CFO | 41,525 | — | — | 41,525 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 5:25 pm EST | Namal NawanaChief Executive Officer, Director | 141,562 | — | — | 141,562 | — | |
| Feb 3, 2016 MForm 4 → | Mar 2, 5:23 pm EST | Namal NawanaChief Executive Officer, Director | 50,000 | — | — | 100,000 | — | late |
| Feb 1, 2016 MForm 4 → | Feb 3, 5:24 pm EST | Melissa GuerdanSVP, Global Quality & Reg. | 2,500 | — | — | 4,415 | — | |
| Dec 30, 2015 MForm 4 → | Jan 4, 2016, 5:10 pm EST | Namal NawanaChief Executive Officer, Director | 100,000 | — | — | 0 | — | |
| Oct 31, 2015 MForm 4 → | Nov 3, 9:38 pm EST | Namal NawanaChief Executive Officer, Director | 16,666 | — | — | 33,334 | — | |
| Aug 31, 2015 MForm 4 → | Sep 2, 4:53 pm EDT | Ellen ChiniaraGC, Chief Ethics Officer&Sec | 6,666 | — | — | 13,334 | — | |
| Aug 31, 2015 MForm 4 → | Sep 2, 4:52 pm EDT | Mark GladwellSenior VP, Global Operations | 32,513 | — | — | 4,750 | — | |
| Aug 31, 2015 MForm 4 → | Sep 2, 4:52 pm EDT | Robert Bernard HargadonSVP, Global Human Resources | 6,666 | — | — | 13,334 | — | |
| Aug 31, 2015 MForm 4 → | Sep 2, 4:52 pm EDT | Carla FlakneVP, Chief Accounting Officer | 3,333 | — | — | 6,667 | — | |
| Aug 31, 2015 MForm 4 → | Sep 2, 4:51 pm EDT | Avi PelossofGlobalPres, Infectious Disease | 6,666 | — | — | 13,334 | — | |
| Aug 31, 2015 MForm 4 → | Sep 2, 4:51 pm EDT | Melissa GuerdanSVP, Global Quality & Reg. | 13,333 | — | — | 4,555 | — | |
| Aug 31, 2015 MForm 4 → | Sep 2, 4:51 pm EDT | Daniella CrampGlobal Pres., Cardiometabolic | 6,666 | — | — | 13,334 | — | |
| Aug 31, 2015 MForm 4 → | Sep 2, 4:50 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 6,666 | — | — | 13,334 | — | |
| Aug 31, 2015 MForm 4 → | Sep 2, 4:50 pm EDT | John BridgenSr VP, Business Develop | 5,000 | — | — | 10,000 | — | |
| Aug 31, 2015 AForm 4 → | Sep 2, 4:50 pm EDT | Geoffrey S GinsburgDirector | 10,443 | — | — | 10,443 | — | |
| Aug 14, 2015 MForm 4 → | Aug 18, 4:50 pm EDT | Sanjay MalkaniGlobal Pres., Toxicology | 31,460 | — | — | 7,500 | — |